Shares of Krishna Institute of Medical Sciences (KIMS) soared to an all-time high on the Bombay Stock Exchange (BSE), reaching ₹2,564.15 per share in intraday trading on Wednesday, reflecting a 3.55% increase. This surge follows the announcement of a 1:5 stock split, an event that has sparked considerable interest among investors, particularly those involved in share market investment.
Details of the stock split announcement
The significant rise in KIMS' share price comes after the hospital chain revealed on Tuesday that September 13, 2024, has been designated as the record date for the stock split. According to the company's official exchange filing, shareholders on record as of this date will receive five shares for every one share they currently hold, effectively subdividing each ₹10 equity share into five fully paid-up equity shares with a face value of ₹2 each. This decision was approved by the shareholders during the 22nd Annual General Meeting held on August 29, 2024.
A stock split is a strategic move often employed by companies to enhance the affordability of their shares, thereby broadening the investor base and improving liquidity in the market. For existing shareholders, this means that while the number of shares they own will increase, the overall value of their investment remains the same. The subdivision of shares makes the stock more accessible to a larger pool of investors, which can drive demand and support long-term growth in share market investment.
KIMS' financial performance and market reaction
Despite the positive market reaction to the stock split news, KIMS' recent financial performance has been less than stellar. The hospital chain reported a 29% decline in consolidated net profit for the March quarter of the 2023-24 financial year, amounting to ₹65.4 crore. This represents a sharp drop from the ₹93.2 crore net profit recorded during the same period in the previous year. However, the company did see a 10% increase in revenue, with earnings from operations rising to ₹634 crore, up from ₹576 crore in the corresponding quarter of the previous year.
At 11:34 AM on Wednesday, KIMS shares were trading 1.05% higher at ₹2,590.95 per share on the BSE, a stark contrast to the BSE Sensex, which was down 0.51% at 82,132 points. The company's shares are currently trading at a price-to-earnings (P/E) multiple of 87.92 times, with an earnings per share (EPS) of ₹29.17. This valuation suggests that investors are optimistic about the company's future prospects despite the recent dip in profits.
Market outlook
The announcement of the stock split appears to have revitalised investor interest in KIMS, driving its shares to a new lifetime high. While the stock split itself does not change the fundamental value of the company, it is perceived as a positive signal to the market, potentially leading to increased demand for the shares.
For those engaged in share market investment, the stock split presents an opportunity to acquire KIMS shares at a lower entry price, potentially reaping the benefits as the company's market position strengthens. As KIMS continues to expand its operations in Andhra Pradesh and Telangana, the long-term outlook for the company remains promising, particularly if it can overcome its recent profit challenges and capitalise on the growing demand for healthcare services in India.
For android only